<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED FINANCIAL STATEMENTS OF T CELL SCIENCES, INC. FOR THE SIX MONTHS ENDED JUNE 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-START> JAN-01-1998 <PERIOD-END> JUN-30-1998 <EXCHANGE-RATE> 1 <CASH> 5,217,400 <SECURITIES> 0 <RECEIVABLES> 6,400 <ALLOWANCES> 0 <INVENTORY> 100 <CURRENT-ASSETS> 6,664,000 <PP&E> 3,092,800 <DEPRECIATION> (2,750,900) <TOTAL-ASSETS> 9,836,300 <CURRENT-LIABILITIES> 1,940,800 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 28,500 <OTHER-SE> 7,117,000 <TOTAL-LIABILITY-AND-EQUITY> 9,836,300 <SALES> 35,000 <TOTAL-REVENUES> 670,900 <CGS> 17,900 <TOTAL-COSTS> 3,764,600 <OTHER-EXPENSES> (185,600) <LOSS-PROVISION> 0 <INTEREST-EXPENSE> (210,000) <INCOME-PRETAX> (2,716,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (2,716,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (2,716,000) <EPS-PRIMARY> (0.10) <EPS-DILUTED> (0.10)